Palatin Technologies Presents At The 9th European Society For Sexual Medicine (ESSM) Congress
Wed, 06 Dec 2006 08:00 AM EST
... Palatin Technologies, Inc. (Amex: PTN) today announced it presented results from two Phase 2B trials evaluating bremelanotide for the treatment of male erectile dysfunction (ED) at the 9th European Society for Sexual Medicine (ESSM) Congress at the Hofburg Convention Center, Vienna on December 5, 2006. [click link for full article] ...
Related Topics
- Rape
- Sexual Health
- Sexual Harassment
- Sexual Dysfunction
- Atherosclerosis
- Sexual Violence
- Medicines
- About Your Medicines
- Holistic medicine
- Sports Medicine
- Female Sexual Dysfunction
- Sexual Health Issues
- Folk medicine
- Emergency Medicine
- Alternative Medicine
- Over-the-Counter Medicines
- Sexual Abuse/assault
- Herbal Medicine
- Traditional Chinese Medicine
- Complementary medicine

Not Signed In -


